Metraipolis › archive › dc_5d657d916643
Estimation of Dermal Exposure to Volatile Organic Compounds (VOCs) from Feminine Hygiene Products: Integrating Measurement Data and Physiologically Based… — Europe PMC PMID:40344599
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40344599
- DOI
- 10.1289/ehp15418
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T09:50:51.493Z
- SHA-256 of the archived text
be057188f04cab2fc629afdcc3bbaaeb1b8b66d4da8ee17e1fc23e032078f19a- Stable URL of this page
https://metraipolis.com/documento/dc_5d657d916643
How to cite
Estimation of Dermal Exposure to Volatile Organic Compounds (VOCs) from Feminine Hygiene Products: Integrating Measurement Data and Physiologically Based… — Europe PMC PMID:40344599 — Europe PMC (en), https://europepmc.org/article/MED/40344599 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_5d657d916643 (Metraipolis archive dc_5d657d916643, sha256 be057188f04cab2fc629afdcc3bbaaeb1b8b66d4da8ee17e1fc23e032078f19a)
BibTeX
@misc{dc5d657d916643,
title = {Estimation of Dermal Exposure to Volatile Organic Compounds (VOCs) from Feminine Hygiene Products: Integrating Measurement Data and Physiologically Based… — Europe PMC PMID:40344599},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40344599},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_5d657d916643; sha256 be057188f04cab2fc629afdcc3bbaaeb1b8b66d4da8ee17e1fc23e032078f19a},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/40344599. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: An increasing number of studies have reported noteworthy health risks associated with dermal exposure to volatile organic compounds (VOCs) from feminine hygiene products (FHPs). Objectives: This study sought to address the gap in understanding the absorption, distribution, metabolism, and excretion dynamics of dermal exposure to VOCs from FHPs and to identify chemicals and products that could cause significant body burden. Methods: We used measured contents of eight widely present VOCs across five categories of FHPs to estimate dermal exposure, and applied a physiologically based toxicokinetic (PBTK) modeling approach to elucidate VOC toxicokinetics in human body tissues. Inhalation exposure estimates were derived from 20 air samples collected via passive sampling and analyzed using a thermal desorption system coupled with gas chromatography-mass spectrometry. Predicted urinary VOC concentrations based on dermal and inhalation exposure were validated against 99 measurements from 25 females. Results: Via skin absorption, the estimated levels of most target VOCs in nearly all tissues, except adipose and the rest of the body, rapidly peaked within an hour of product use. Specifically, p-cymene was estimated to reach ∼2.23 ng/mL in adipose tissue before decreasing over several hours due to efficient excretion pathways, including liver metabolism and exhalation. The model estimated that although the majority of absorbed VOCs (78.9%) were eliminated via liver metabolism, exhalation, and urine excretion, VOCs with log Kow higher than 3.5, such as p-cymene, hexane, and n-nonane, exhibited a potential cumulative trend in adipose tissue. This trend resulted in the estimated VOC concentrations in adipose tissue being 1 to 4 orders of magnitude higher than those estimated in other tissues. In certain cases, n-nonane posed a potential noncancer risk (up to 0.07), and benzene presented a notable cancer risk (up to 1.82×10-7), primarily attributed to washes and moisturizers, respectively. Discussion: These findings reveal potential significant body burden and health risks associated with dermal exposure to VOCs from FHPs, warranting further research and regulatory measures. Comprehensive assessment of internal exposure by integrating with toxicokinetic modeling to elucidate chemical distribution in various tissues is recommended, rather than by measuring only one type of biomarker, to illustrate exposure variances and ensure accurate risk assessment. https://doi.org/10.1289/EHP15418. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2025 (prima pubblicazione 2025-06-20). Identificativi: PMID 40344599 · PMCID PMC12180445 · DOI 10.1289/ehp15418. Descrittori MeSH principali: Cosmetics; Air Pollutants; Environmental Exposure; Volatile Organic Compounds. Pagina: https://europepmc.org/article/MED/40344599 — https://doi.org/10.1289/ehp15418. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T09:43:38.060Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.